Delivery Order SPE2DE21D7020-SPE2D626F97LS

<p>The Defense Health Agency's Medical Supply Chain issued a delivery order to Boston Scientific Corp on February 11, 2026, for enroute TCAR stents with a ceiling value of $16,998.67. The order is fixed-price with economic price adjustment and has an ultimate completion date of February 19, 2026. Place of performance is Marlborough, MA.</p>

<p>The Defense Health Agency's Medical Supply Chain issued a $4,977 delivery order to Boston Scientific Corp on March 5, 2026, for an enroute transcarotid neuroprotection system, with ultimate completion on March 12, 2026.</p> <p>Place of performance is Marlborough, MA. Pricing is fixed price with economic price adjustment. No set-aside was used.</p>

The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,326.30 to Boston Scientific Corp for EnRoute TCAR stents on July 25, 2025, with an ultimate completion date of August 1, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures...

Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,652.60 for enroute TCAR stents on September 26, 2025, with an ultimate completion date of October 3, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division and will be performed in Marlborough, MA. The contract represents no set-aside designation, allowing Boston...

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a $6,652.60 delivery order by the Defense Health Agency's Medical Supply Chain division on December 23, 2025, for enroute TCAR (transcarotid) stents. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of December 31, 2025. No small business set-aside was applied to this award, allowing Boston Scientific to compete on an unrestricted...

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,326.30 for enroute TCAR (transcarotid) stents under the Defense Health Agency's Medical Supply Chain program. The award, issued December 11, 2025, with an ultimate completion date of December 18, 2025, carries fixed-price pricing with economic price adjustment provisions and was made without a small business set-aside. The delivery order will be performed at Boston Scientific's...

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,652.60 for enroute TCAR stents under a fixed-price contract with economic price adjustment provisions. The award, issued on October 30, 2025, with an ultimate completion date of November 6, 2025, represents a delivery order against an existing contract vehicle with the Defense Health Agency's Medical Supply Chain division. No small business set-aside was utilized for this award,...

Boston Scientific Corp has been awarded a delivery order valued at $14,245.70 for EnRoute TCAR stents under a contract with the Defense Health Agency's Medical Supply Chain on August 26, 2025, with an ultimate completion date of September 3, 2025. This fixed-price contract with economic price adjustment provisions is unset-aside and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. TCAR (Transcarotid Artery Revascularization) stents are specialized cardiovascular...

Boston Scientific Corp has been awarded a delivery order valued at $11,389.65 for enroute TCAR stents under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this award, indicating open...

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,593.10 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract involves the supply of enroute TCAR (transcarotid artery revascularization) stents, specialized cardiovascular intervention devices used in minimally invasive procedures. This delivery order was competitively awarded with no...